1 research outputs found
Vitamin B6 Tethered Endosomal pH Responsive Lipid Nanoparticles for Triggered Intracellular Release of Doxorubicin
This study reports the development
of Vitamin B6 (VitB6) modified
pH sensitive charge reversal nanoparticles for efficient intracellular
delivery of Doxorubicin (DOX). Herein, VitB6 was conjugated to stearic
acid, and the nanoparticles of the lipid were formulated by solvent
injection method (DOX-B6-SA-NP). Because of the p<i>K</i><sub>a</sub> (5.6) of VitB6, DOX-B6-SA-NP showed positive charge
and enhanced release of DOX at pH 5. Confocal microscopy illustrated
that DOX-B6-SA-NP treatment kept higher DOX accumulation inside the
cells than conventional pH insensitive lipid nanoparticles (DOX-SA-NP).
The cationic charge of nanoparticles subsequently facilitated the
endosomal escape and promoted the nuclear accumulation of DOX. Furthermore,
in vitro cytotoxicity, apoptosis, cell cycle arrest, and mitochondrial
membrane depolarization studies supported the enhanced efficacy of
DOX-B6-SA-NP in comparison to free DOX and DOX-SA-NP. Intravenous
pharmacokinetics and biodistribution investigations indicated that
pH sensitive nanoparticles can significantly prolong the blood circulation
time of DOX in biological system and increase the drug accumulation
to tumor site. Consequent to this, DOX-B6-SA-NP also exhibited much
enhanced therapeutic efficacy and lower toxicity in tumor-bearing
rats compared to free DOX. The reduction in toxicity was confirmed
by histological and survival analysis. In conclusion, these results
suggest that the VitB6 modified charge reversal nanoparticles can
be a novel platform for the successful delivery of anticancer drugs